Derivative Instruments (Tables)

3 Months Ended

Mar. 31, 2016

Derivative Instruments (Tables) [Abstract]

Impact of derivative instruments on the statement of operations and OCI

		March 31, 2016		December 31, 2015
Derivatives designated as net investment hedges:
Denominated in Canadian Dollars	$	1,175,000	$	1,175,000
Denominated in Pounds Sterling	£	550,000	£	550,000
Financial instruments designated as net investment hedges:
Denominated in Canadian Dollars	$	250,000	$	250,000
Denominated in Pounds Sterling	£	1,050,000	£	1,050,000
Derivatives designated as cash flow hedges
Denominated in U.S. Dollars	$	57,000	$	57,000
Denominated in Canadian Dollars	$	72,000	$	72,000
Denominated in Pounds Sterling	£	60,000	£	60,000
Derivative instruments not designated:
Denominated in Canadian Dollars	$	47,000	$	47,000

		Three Months Ended
		March 31,
	Location		2016		2015
Gain (loss) on interest rate swaps reclassified from AOCI into income (effective portion)	Interest expense	$	(483)	$	(466)
Gain (loss) on forward exchange contracts recognized in income	Interest expense		(1,327)		2,747
Loss (gain) on option exercise(1)	Loss (gain) on derivatives, net		-		(58,427)
Gain (loss) on foreign exchange contracts and term loans designated as net investment hedge recognized in OCI	OCI		(2,739)		184,051
(1) In April 2011, we completed the acquisition of substantially all of the real estate assets of privately-owned Genesis Healthcare Corporation. In conjunction with this transaction, we received the option to acquire an ownership interest in Genesis Healthcare. In February 2015, Genesis Healthcare closed on a transaction to merge with Skilled Healthcare Group to become a publicly traded company which required us to record the value of the derivative asset due to the net settlement feature.